Her main research concerns Vaccination, Cervical cancer, Gynecology, Demography and Genital warts. The various areas that Julia M.L. Brotherton examines in her Vaccination study include Young adult, Incidence, Papillomavirus Vaccines and Obstetrics. Her Cervical cancer study integrates concerns from other disciplines, such as Anal cancer, Family medicine and Cervix.
Within one scientific family, Julia M.L. Brotherton focuses on topics pertaining to Cohort under Gynecology, and may sometimes address concerns connected to Vaccination coverage and Human papillomavirus vaccine. The study incorporates disciplines such as Pap test and Herd immunity in addition to Genital warts. Her Immunology research focuses on HPV infection and how it connects with Papillomaviridae, Relative risk and Public health.
Her main research concerns Vaccination, Cervical cancer, Cervical screening, Gynecology and Family medicine. The Vaccination study combines topics in areas such as Young adult, Demography, Papillomavirus Vaccines, Genital warts and HPV infection. Julia M.L. Brotherton has included themes like Cytology and Cervix in her Cervical cancer study.
The study incorporates disciplines such as Cancer screening, Human papillomavirus, Mass screening, Obstetrics and Cervical intraepithelial neoplasia in addition to Cervical screening. Her Gynecology study integrates concerns from other disciplines, such as Pap test and Linear Array HPV Genotyping Test. Her Family medicine study which covers Public health that intersects with Epidemiology.
Her primary scientific interests are in Cervical screening, Cervical cancer, Vaccination, Family medicine and Human papillomavirus. Her Cervical screening research incorporates elements of Psychological intervention, Cervical cytology, Confidence interval, Cytology and Obstetrics. Her study on Cervical cancer also encompasses disciplines like
The Vaccination study combines topics in areas such as HPV infection, Demography, Internal medicine, Hpv vaccination and Pediatrics. The various areas that she examines in her Human papillomavirus study include Childhood immunisation, Epidemiology and Papillomavirus Vaccines. Her Cervical intraepithelial neoplasia research is multidisciplinary, relying on both Incidence, Cervix, Young adult, Papillomaviridae and Genotyping.
Julia M.L. Brotherton mainly focuses on Cervical screening, Vaccination, Cervical cancer, Cervical intraepithelial neoplasia and Human papillomavirus. Julia M.L. Brotherton has researched Cervical screening in several fields, including Cytology, Routine screening, Family medicine and Obstetrics. Her work deals with themes such as Hpv vaccination, Demography and Incidence, which intersect with Vaccination.
Her Incidence research integrates issues from Herd immunity, Relative risk, Mortality rate, Genital warts and HPV vaccines. Her Cervical cancer study is concerned with Cancer in general. Her studies deal with areas such as Papillomaviridae and HPV infection as well as Cervical intraepithelial neoplasia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Melanie Drolet;Elodie Benard;Marie-Claude Boily;Marie-Claude Boily;Hammad Ali.
Lancet Infectious Diseases (2015)
Comprehensive control of human papillomavirus infections and related diseases.
F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki.
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
Julia M L Brotherton;Masha Fridman;Cathryn L May;Genevieve Chappell.
The Lancet (2011)
Human Papillomavirus Vaccine Introduction – The First Five Years
Lauri E Markowitz;Vivien Tsu;Shelley L Deeks;Heather Cubie.
Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
Sepehr N Tabrizi;Julia Brotherton;John M Kaldor;S Rachel Skinner.
The Journal of Infectious Diseases (2012)
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
Dorota M Gertig;Julia M L Brotherton;Alison C Budd;Kelly Drennan.
BMC Medicine (2013)
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes : updated systematic review and meta-analysis
Mélanie Drolet;Élodie Bénard;Norma Pérez;Marc Brisson;Marc Brisson.
The Lancet (2019)
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
Sepehr N Tabrizi;Julia Brotherton;John Martin Kaldor;S Rachel Skinner.
Lancet Infectious Diseases (2014)
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
Marc Arbyn;Silvia De Sanjosé;Mona Saraiya;Mario Sideri.
International Journal of Cancer (2012)
Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
Elizabeth Crowe;Nirmala Pandeya;Julia M L Brotherton;Annette J Dobson.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: